menu search

Idorsia reacquires the world-wide rights to aprocitentan

Idorsia will pay Janssen a conditional consideration up to a total cap of CHF 306 million Idorsia is initiating activities to determine the best appro...

September 6, 2023, 5:14 am


Search within

Pages Search Results: